sodium fluoride has been researched along with Atheroma in 51 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with stable coronary artery disease (CAD) and high-risk plaques (HRPs) on coronary computed tomography angiography (CTA), we sought to define qualitative and quantitative CTA predictors of abnormal coronary 18F-sodium fluoride uptake (18F-NaF) by positron emission tomography (PET)." | 7.96 | Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. ( Berman, DS; Cadet, S; Chang, HJ; Dey, D; Dweck, MR; Friedman, JD; Huynh, PT; Kwiecinski, J; Lee, SE; Newby, DE; Otaki, Y; Slomka, PJ; Tamarappoo, B; Yun, M, 2020) |
| "A significant majority of atherosclerotic plaque ruptures occur in coronary arteries exhibiting none or only modest luminal narrowing on coronary angiography." | 6.49 | Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. ( Chen, W; Dilsizian, V, 2013) |
| "The rabbits were divided into 2 groups as follows: an atherosclerosis group (n = 10) and an atorvastatin group (n = 10)." | 4.02 | Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study. ( Chen, X; Liang, Z; Nie, M; Yan, Y; Zhang, X; Zhao, Q, 2021) |
| "In patients with stable coronary artery disease (CAD) and high-risk plaques (HRPs) on coronary computed tomography angiography (CTA), we sought to define qualitative and quantitative CTA predictors of abnormal coronary 18F-sodium fluoride uptake (18F-NaF) by positron emission tomography (PET)." | 3.96 | Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. ( Berman, DS; Cadet, S; Chang, HJ; Dey, D; Dweck, MR; Friedman, JD; Huynh, PT; Kwiecinski, J; Lee, SE; Newby, DE; Otaki, Y; Slomka, PJ; Tamarappoo, B; Yun, M, 2020) |
| "Ruptured coronary atherosclerotic plaques commonly cause acute myocardial infarction." | 2.82 | Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques. ( Berman, DS; Dey, D; Dweck, MR; Fletcher, A; Germano, G; Joshi, NV; Li, D; Motwani, M; Newby, DE; Rubeaux, M; Slomka, PJ; Thomson, LE, 2016) |
| "A significant majority of atherosclerotic plaque ruptures occur in coronary arteries exhibiting none or only modest luminal narrowing on coronary angiography." | 2.49 | Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. ( Chen, W; Dilsizian, V, 2013) |
| "To assess whether coronary atherosclerotic plaque activity as assessed by noninvasive imaging is associated with recurrent coronary events in patients with myocardial infarction." | 1.91 | Coronary Atherosclerotic Plaque Activity and Future Coronary Events. ( Adamson, PD; Arumugam, P; Berman, D; Bularga, A; Calvert, PA; Daghem, M; Dawson, D; Dey, D; Dweck, MR; Fletcher, A; Forsyth, L; Greenwood, JP; Kwiecinski, J; Lee, RJ; Lewis, S; Meah, MN; Mills, NL; Moss, A; Murdoch, L; Newby, DE; Rudd, JHF; Sabharwal, N; Slomka, P; Townend, JN; Tzolos, E; van Beek, EJR; Verjans, J; Wang, KL; Williams, MC, 2023) |
| "The identification of the vulnerable atheroma plaque could allow a more effective treatment of cerebrovascular accident (CVA)." | 1.43 | New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results. ( Banzo, I; Carril, JM; Ibáñez-Bravo, S; Jiménez-Alonso, M; Jiménez-Bonilla, J; López-Defilló, J; Martínez-Amador, N; Martínez-Rodríguez, I; Quirce, R; Revilla, MA, 2016) |
| "Formation and progression of atherosclerotic plaque is a dynamic and complex process involving various pathophysiologic steps including inflammation and calcification." | 1.37 | Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. ( Apostolova, I; Derlin, T; Habermann, CR; Klutmann, S; Mester, J; Papp, L; Tóth, Z; Wisotzki, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 30 (58.82) | 24.3611 |
| 2020's | 21 (41.18) | 2.80 |
| Authors | Studies |
|---|---|
| Fayad, ZA | 2 |
| Robson, PM | 1 |
| Zhang, X | 1 |
| Chen, X | 1 |
| Liang, Z | 1 |
| Nie, M | 1 |
| Yan, Y | 1 |
| Zhao, Q | 1 |
| Fletcher, AJ | 2 |
| Tew, YY | 1 |
| Tzolos, E | 3 |
| Joshi, SS | 1 |
| Kaczynski, J | 1 |
| Nash, J | 2 |
| Debono, S | 1 |
| Lembo, M | 1 |
| Kwiecinski, J | 8 |
| Bing, R | 1 |
| Syed, MBJ | 1 |
| Doris, MK | 2 |
| van Beek, EJR | 3 |
| Moss, AJ | 1 |
| Jenkins, WS | 1 |
| Walker, NL | 1 |
| Joshi, NV | 4 |
| Pawade, TA | 1 |
| Adamson, PD | 3 |
| Whiteley, WN | 1 |
| Wardlaw, JM | 1 |
| Slomka, PJ | 6 |
| Williams, MC | 4 |
| Newby, DE | 12 |
| Dweck, MR | 11 |
| Meah, MN | 2 |
| Cadet, S | 2 |
| Grodecki, K | 1 |
| Joshi, N | 1 |
| Lai, C | 1 |
| Tavares, AAS | 1 |
| MacAskill, MG | 1 |
| Dey, D | 4 |
| Baker, AH | 1 |
| Leipsic, J | 1 |
| Berman, DS | 4 |
| Sellers, SL | 1 |
| Alavi, A | 4 |
| Werner, TJ | 1 |
| Høilund-Carlsen, PF | 2 |
| Revheim, ME | 1 |
| Yang, W | 1 |
| Zhong, Z | 1 |
| Feng, G | 1 |
| Wang, Z | 1 |
| Kim, JM | 2 |
| Lee, R | 1 |
| Jeong, HB | 1 |
| Park, KY | 2 |
| Seok, JW | 2 |
| Moss, A | 1 |
| Daghem, M | 1 |
| Wang, KL | 1 |
| Bularga, A | 1 |
| Fletcher, A | 2 |
| Dawson, D | 1 |
| Arumugam, P | 1 |
| Sabharwal, N | 1 |
| Greenwood, JP | 1 |
| Townend, JN | 1 |
| Calvert, PA | 2 |
| Rudd, JHF | 2 |
| Berman, D | 1 |
| Verjans, J | 1 |
| Slomka, P | 1 |
| Forsyth, L | 1 |
| Murdoch, L | 1 |
| Lee, RJ | 1 |
| Lewis, S | 1 |
| Mills, NL | 2 |
| Oliveira-Santos, M | 3 |
| McMahon, G | 1 |
| Castelo-Branco, M | 3 |
| Silva, R | 3 |
| Gomes, A | 2 |
| Chichorro, N | 1 |
| Abrunhosa, A | 3 |
| Donato, P | 1 |
| de Lima, JP | 1 |
| Pego, M | 2 |
| Gonçalves, L | 3 |
| Ferreira, MJ | 2 |
| Osborne, MT | 2 |
| Abbasi, TA | 1 |
| Albaghdadi, MS | 2 |
| Dietz, M | 1 |
| Chironi, G | 1 |
| Faraggi, M | 1 |
| Lassen, ML | 1 |
| Borges-Rosa, J | 1 |
| da Silva, NP | 1 |
| Mayer, J | 1 |
| Jin, Y | 1 |
| Wurster, TH | 1 |
| Makowski, MR | 1 |
| Kolbitsch, C | 1 |
| Nogales, P | 1 |
| Velasco, C | 1 |
| Mota-Cobián, A | 1 |
| González-Cintado, L | 1 |
| Mota, RA | 1 |
| España, S | 1 |
| Mateo, J | 1 |
| Bentzon, JF | 1 |
| Hsu, JJ | 1 |
| Tintut, Y | 1 |
| Demer, LL | 1 |
| Raggi, P | 2 |
| Lee, JM | 2 |
| Bang, JI | 2 |
| Koo, BK | 2 |
| Hwang, D | 1 |
| Park, J | 2 |
| Zhang, J | 2 |
| Yaliang, T | 1 |
| Suh, M | 1 |
| Paeng, JC | 2 |
| Shiono, Y | 1 |
| Kubo, T | 2 |
| Akasaka, T | 2 |
| Strauss, HW | 1 |
| Narula, J | 2 |
| Zhang, Y | 1 |
| Li, H | 1 |
| Jia, Y | 1 |
| Yang, P | 1 |
| Zhao, F | 1 |
| Wang, W | 1 |
| Liu, W | 1 |
| Chen, G | 1 |
| Zhuang, X | 1 |
| Li, J | 1 |
| Bellinge, JW | 1 |
| Francis, RJ | 1 |
| Majeed, K | 1 |
| Watts, GF | 1 |
| Schultz, CJ | 1 |
| Lee, ES | 1 |
| Kwon, OS | 1 |
| Tavakoli, S | 1 |
| Sadeghi, MM | 1 |
| Zaha, VG | 1 |
| Joshi, PH | 1 |
| McGuire, DK | 1 |
| Moghbel, MC | 1 |
| Gerke, O | 1 |
| Kolossváry, M | 1 |
| Merkely, B | 1 |
| Maurovich-Horvat, P | 1 |
| Prandini, N | 1 |
| Ligabue, G | 1 |
| Braglia, G | 1 |
| Esposito, F | 1 |
| Milic, J | 1 |
| Malagoli, A | 1 |
| Scaglioni, R | 1 |
| Besutti, G | 1 |
| Beghetto, B | 1 |
| Nardini, G | 1 |
| Roncaglia, E | 1 |
| Mussini, C | 1 |
| Guaraldi, G | 1 |
| Chowdhury, MM | 1 |
| Tarkin, JM | 1 |
| Evans, NR | 1 |
| Le, EPV | 1 |
| Berrett, TB | 1 |
| Sadat, U | 1 |
| Joshi, FR | 2 |
| Warburton, EA | 1 |
| Buscombe, JR | 2 |
| Hayes, PD | 1 |
| Coughlin, PA | 1 |
| Lee, SE | 1 |
| Tamarappoo, B | 1 |
| Otaki, Y | 1 |
| Huynh, PT | 1 |
| Friedman, JD | 1 |
| Yun, M | 1 |
| Chang, HJ | 1 |
| Chen, W | 1 |
| Dilsizian, V | 1 |
| Vesey, AT | 1 |
| Shah, AS | 1 |
| Craighead, FH | 1 |
| Yeoh, SE | 1 |
| Wallace, W | 1 |
| Salter, D | 1 |
| Fletcher, AM | 1 |
| van Beek, EJ | 1 |
| Flapan, AD | 1 |
| Uren, NG | 1 |
| Behan, MW | 1 |
| Cruden, NL | 1 |
| Fox, KA | 1 |
| Rudd, JH | 2 |
| Morbelli, S | 1 |
| Fiz, F | 1 |
| Piccardo, A | 1 |
| Picori, L | 1 |
| Massollo, M | 1 |
| Pestarino, E | 1 |
| Marini, C | 1 |
| Cabria, M | 1 |
| Democrito, A | 1 |
| Cittadini, G | 1 |
| Villavecchia, G | 1 |
| Bruzzi, P | 1 |
| Sambuceti, G | 1 |
| Toor, IS | 1 |
| Vesey, A | 1 |
| Hung, GU | 1 |
| Hung, CH | 1 |
| Chen, TY | 1 |
| Kung, WM | 1 |
| Wei, CY | 1 |
| Kao, CH | 1 |
| Uchiyama, S | 1 |
| Quirce, R | 1 |
| Martínez-Rodríguez, I | 1 |
| Banzo, I | 1 |
| Jiménez-Bonilla, J | 1 |
| Martínez-Amador, N | 1 |
| Ibáñez-Bravo, S | 1 |
| López-Defilló, J | 1 |
| Jiménez-Alonso, M | 1 |
| Revilla, MA | 1 |
| Carril, JM | 1 |
| McKenney-Drake, ML | 1 |
| Territo, PR | 1 |
| Salavati, A | 1 |
| Houshmand, S | 1 |
| Persohn, S | 1 |
| Liang, Y | 1 |
| Alloosh, M | 1 |
| Moe, SM | 1 |
| Weaver, CM | 1 |
| Sturek, M | 1 |
| Rubeaux, M | 1 |
| Motwani, M | 1 |
| Thomson, LE | 1 |
| Germano, G | 1 |
| Li, D | 1 |
| Brammen, L | 1 |
| Steiner, S | 1 |
| Berent, R | 1 |
| Sinzinger, H | 1 |
| Cocker, MS | 1 |
| Spence, JD | 1 |
| Hammond, R | 1 |
| Wells, G | 1 |
| deKemp, RA | 1 |
| Lum, C | 1 |
| Adeeko, A | 1 |
| Yaffe, MJ | 1 |
| Leung, E | 1 |
| Hill, A | 1 |
| Nagpal, S | 1 |
| Stotts, G | 1 |
| Alturkustani, M | 1 |
| Hammond, L | 1 |
| DaSilva, J | 1 |
| Hadizad, T | 1 |
| Tardif, JC | 1 |
| Beanlands, RS | 1 |
| Ferreira, MJV | 1 |
| Ferreira, N | 1 |
| Lima, J | 1 |
| Cal-Gonzalez, J | 1 |
| Li, X | 1 |
| Heber, D | 1 |
| Rausch, I | 1 |
| Moore, SC | 1 |
| Schäfers, K | 1 |
| Hacker, M | 1 |
| Beyer, T | 1 |
| Tawakol, A | 1 |
| Derlin, T | 2 |
| Wisotzki, C | 2 |
| Richter, U | 1 |
| Apostolova, I | 2 |
| Bannas, P | 1 |
| Weber, C | 1 |
| Mester, J | 2 |
| Klutmann, S | 2 |
| Tóth, Z | 1 |
| Papp, L | 1 |
| Habermann, CR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational PET/CT Study Examining the Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis[NCT01358513] | 121 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| Evaluating the Diagnostic Accuracy of 18F-sodium Fluoride Positron Emission Tomography for Identification of High-risk Vulnerable Coronary Atherosclerotic Plaque in Patients With Coronary Artery Disease[NCT02388412] | 96 participants (Anticipated) | Observational [Patient Registry] | 2015-03-31 | Recruiting | |||
| Dual Antiplatelet Therapy to Inhibit Coronary Atherosclerosis and Myocardial Injury in Patients With Necrotic High-Risk Coronary Plaque Disease[NCT02110303] | Phase 2/Phase 3 | 220 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Validation of PET-MRI for Cardiovascular Disease[NCT02988531] | 20 participants (Anticipated) | Interventional | 2017-02-09 | Completed | |||
| Prediction of Recurrent Events With 18F-Fluoride to Identify Ruptured and High-risk Coronary Artery Plaques in Patients With Myocardial Infarction[NCT02278211] | 706 participants (Actual) | Observational | 2015-10-31 | Completed | |||
| Characterizing Vulnerable Plaques in Non-ST-Elevation Myocardial Infarction Using 18F-NaF Positron Emission Tomography - Cardiac Magnetic Resonance Imaging: A Feasibility Study[NCT02563964] | 10 participants (Actual) | Observational [Patient Registry] | 2017-09-01 | Terminated (stopped due to Logistical reasons and slow recruitment) | |||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| Combined Positron Emission Tomography and Magnetic Resonance Imaging of Coronary Atherothrombosis[NCT03618303] | 40 participants (Anticipated) | Interventional | 2018-07-16 | Recruiting | |||
| Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT[NCT03233243] | Phase 4 | 40 participants (Actual) | Interventional | 2020-07-27 | Completed | ||
| SALTIRE II: Bisphosphonates and RANKL Inhibition in Aortic Stenosis[NCT02132026] | Phase 2 | 152 participants (Actual) | Interventional | 2014-11-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for sodium fluoride and Atheroma
| Article | Year |
|---|---|
Advances in positron emission tomography tracers related to vascular calcification.
Topics: Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomog | 2022 |
Vulnerable plaque imaging using
Topics: Computed Tomography Angiography; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Movement; | 2020 |
Advances in Quantitative Analysis of
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission | 2021 |
Lipids and cardiovascular calcification: contributions to plaque vulnerability.
Topics: Animals; Humans; Lipids; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; | 2021 |
Evolving Role of PET in Detecting and Characterizing Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Contrast Media; Coronary Artery Disease; Disease Models, An | 2019 |
Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Topics: Calcinosis; Coronary Angiography; Coronary Artery Disease; Disease Progression; Early Diagnosis; Fem | 2013 |
Molecular imaging of the atherosclerotic plaque using positron emission tomography.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; | 2014 |
Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques?
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Multimodal Imaging; Myocardial Infarction; | 2014 |
Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
Topics: Aortic Aneurysm; Atherosclerosis; Coronary Vessels; Fluorodeoxyglucose F18; Gallium Radioisotopes; H | 2015 |
Identification of early vascular calcification with (18)F-sodium fluoride: potential clinical application.
Topics: Disease Progression; Early Diagnosis; Humans; Plaque, Atherosclerotic; Positron Emission Tomography | 2016 |
Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Topics: Animals; Arteries; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecula | 2016 |
2 trials available for sodium fluoride and Atheroma
| Article | Year |
|---|---|
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Topics: Aged; Angina Pectoris; Carotid Stenosis; Confounding Factors, Epidemiologic; Coronary Angiography; C | 2014 |
Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Female; Fluorine Radioisotopes; Humans; Image P | 2016 |
38 other studies available for sodium fluoride and Atheroma
| Article | Year |
|---|---|
Bringing Color to Atherosclerotic Plaque Calcification With
Topics: Calcinosis; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Sodium Fluoride | 2021 |
Atorvastatin Promotes Macrocalcification, But Not Microcalcification in Atherosclerotic Rabbits: An 18F-NaF PET/CT Study.
Topics: Animals; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Calcium; Disease Models, Animal; Fluorine | 2021 |
Thoracic Aortic
Topics: Aortic Valve Stenosis; Atherosclerosis; Calcium; Cardiovascular Diseases; Fluorine Radioisotopes; Hu | 2022 |
Bypass Grafting and Native Coronary Artery Disease Activity.
Topics: Aged; Calcinosis; Calcium; Coronary Angiography; Coronary Artery Disease; Disease Progression; Femal | 2022 |
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission T | 2022 |
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.
Topics: Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emiss | 2022 |
Imaging coronary and aortic microcalcification activity with
Topics: Calcinosis; Fluorine Radioisotopes; Heart; Humans; Plaque, Atherosclerotic; Positron Emission Tomogr | 2022 |
The uptake pattern of 18F-sodium fluoride radioligand in brain tissue after cerebral infarction.
Topics: Aged; Aged, 80 and over; Brain; Cerebral Infarction; Female; Fluorine Radioisotopes; Humans; Ischemi | 2022 |
Coronary Atherosclerotic Plaque Activity and Future Coronary Events.
Topics: Cohort Studies; Coronary Artery Disease; Death; Female; Humans; Male; Myocardial Infarction; Plaque, | 2023 |
Renal artery wall 18F-NaF activity and glomerular filtration rate: an exploratory analysis in a high cardiovascular risk population.
Topics: Aged; Calcinosis; Female; Fluorine Radioisotopes; Glomerular Filtration Rate; Humans; Male; Middle A | 2020 |
Narrowing in on a PET tracer that characterizes coronary atheroma:
Topics: Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission | 2021 |
Reduced 18F-sodium fluoride activity in coronary plaques after statin therapy.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Humans; Hydroxymethylglutaryl-CoA R | 2021 |
Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[
Topics: Aged; Calcinosis; Calcium; Cardiovascular Diseases; Female; Fluorine Radioisotopes; Heart Disease Ri | 2022 |
Evaluation of synergistic image registration for motion-corrected coronary NaF-PET-MR.
Topics: Computer Simulation; Coronary Artery Disease; Coronary Vessels; Fluorine Radioisotopes; Humans; Imag | 2021 |
Analysis of
Topics: Animals; Animals, Genetically Modified; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Disease | 2021 |
The never ending search for the elusive vulnerable plaque.
Topics: Coronary Artery Disease; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomog | 2017 |
Clinical Relevance of
Topics: Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Steno | 2017 |
Topics: Coronary Artery Disease; Fluorides; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; S | 2017 |
Noninvasive Assessment of Carotid Plaques Calcification by
Topics: Calcinosis; Carotid Arteries; Carotid Stenosis; Endarterectomy, Carotid; Female; Fluorine Radioisoto | 2018 |
In search of the vulnerable patient or the vulnerable plaque:
Topics: Cardiovascular Diseases; Coronary Artery Disease; Fluorine Radioisotopes; Humans; Plaque, Atheroscle | 2018 |
Comparison of [
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Ath | 2019 |
Topics: Calcinosis; Fluorides; Humans; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomogr | 2019 |
Probing for Vulnerable Plaque in Patients With Diabetes Mellitus.
Topics: Coronary Artery Disease; Diabetes Mellitus; Humans; Plaque, Atherosclerotic; Sodium Fluoride | 2019 |
Identification of invasive and radionuclide imaging markers of coronary plaque vulnerability using radiomic analysis of coronary computed tomography angiography.
Topics: Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Endosonography | 2019 |
Molecular Imaging of Vascular Calcification with
Topics: Aged; Coronary Artery Disease; Disease Progression; Female; Fluorine Radioisotopes; HIV; HIV Infecti | 2019 |
Vascular Positron Emission Tomography and Restenosis in Symptomatic Peripheral Arterial Disease: A Prospective Clinical Study.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Female; Femoral Artery; Fluorodeoxyglucose F18; Human | 2020 |
Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography.
Topics: Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Fl | 2020 |
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Coronary Artery Disease; Coronary Vessels; Female; Fluorine | 2014 |
Identification of Suspected Ruptured Atherosclerotic Plaque in Acute Ischemic Stroke on (18)F-Sodium Fluoride Positron Emission Tomography-Computed Tomography.
Topics: Aged, 80 and over; Brain Ischemia; Female; Fluorine Radioisotopes; Humans; Plaque, Atherosclerotic; | 2015 |
New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Carotid Arteries; Carotid Artery Diseases; Female; F | 2016 |
(18)F-NaF PET Imaging of Early Coronary Artery Calcification.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Disea | 2016 |
[
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Female; Fluorine Radioisotopes; Humans; Male; Middl | 2017 |
Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT.
Topics: Aged; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron E | 2018 |
Partial volume correction for improved PET quantification in
Topics: Adult; Aged; Coronary Artery Disease; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Pha | 2018 |
Molecular Imaging of Atheroma: Deciphering How and When to Use
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; | 2017 |
In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors.
Topics: Adult; Aged; Aged, 80 and over; Calcinosis; Carotid Artery Diseases; Comorbidity; Female; Germany; H | 2011 |
Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Arteries; Biological Transport; Calcinosis; Female; Flu | 2011 |
Noninvasive imaging in cardiovascular therapy: the promise of coronary arterial ¹⁸F-sodium fluoride uptake as a marker of plaque biology.
Topics: Atherosclerosis; Biological Transport; Biomarkers; Coronary Artery Disease; Coronary Vessels; Diseas | 2012 |